Filing Flows › Companies › Tela Bio › Report card
Tela Bio earnings report card
Every report on file against what analysts and the company itself expected, and what the stock did
Beat rate2 of 3 reports beat the EPS estimate
Tela Bio (TELA) beat the analysts' EPS estimate in 2 of its last 3 reports (67%), by -0.3% on average. Next report: Nov 10, 2026, analysts expect EPS −$0.16.
Beat rate67% of 3
Average surprise-0.3%
Next reportNov 10, 2026
Report by report
| Quarter | Reported | EPS est. | EPS reported | Surprise | Revenue reported |
|---|---|---|---|---|---|
| Q2 2026 | Aug 10, 2026 | −$0.18 | −$0.20 | -12.4% | $19.3M |
| Q4 2025 | Mar 24, 2026 | −$0.18 | −$0.17 | +6.6% | $20.9M |
| Q3 2025 | Nov 13, 2025 | −$0.20 | −$0.19 | +5.0% | $20.7M |
Estimates and reported EPS are the Street's adjusted figures. Revenue reported is from the company's filing. No daily prices are on file for these report days, so the stock's moves are not shown.
Charts
The next report: what to expect → Tela Bio: every quarter →
Read automatically from SEC filings, earnings releases and public estimates; errors are possible. Not investment advice.